The buy box forms part of the investigation currently underway in the EU, which is also looking into whether Amazon violated antitrust rules over its use of business data from independent sellers on its marketplace to benefit its own retail arm. It also scrutinized how the Seattle-based e-commerce giant decides which merchants appear in the so-called buy box - the panel where Amazon highlights sellers of a particular product and is a key tool to drive sales. The CMA’s analysis has focused on how Amazon uses the data it collects on its platform, according to the FT. “The CMA cannot speculate as to which cases it may or may not investigate,” a spokesperson for the regulator said in an email. Read more: Amazon Hit by EU Complaint, Faces New Probe Over Sales small and medium-sized enterprises that account for more than half of everything we sell in our online store,” the company said in a statement. “We continue to work hard to deliver great value and low prices for customers and support the tens of thousands of U.K.
The amount of data and the way with which Amazon protects that data across our AWS, Devices, and Stores businesses shows that we are as good as and responsible as anyone in the world at protecting customers’ data.Amazon declined to comment on the investigation. Members can choose to fill their medications with any pharmacy they prefer, including Amazon Pharmacy.” Amazon also said it, “protects some of the most sensitive data in the world and have been very good stewards of that. According to an Amazon spokesperson, “One Medical continues to offer choice and flexibility. We reached out to Amazon for a statement. And even if Congress doesn’t jump in, enough companies might say, “It’s just not worth wrestling in court, spending millions of dollars on lawyers risking a possible loss. One, it could prod Congress to change the law to pass another statute. But it’s could be strategic because it could do two things. I mean, lawyers don’t like to go to court to lose. With Amazon, the innovation takes place in about 10 minutes.īrancaccio: The head of the Federal Trade Commission, her name is Lina Khan, indicates she might push for some antitrust cases that she’s aware could lose under current law.
I mean, health care, they’re the foot-draggers.
In antitrust, you’re always trying to balance the benefits of a combination versus the potential risks to competition. And it’s not like health care doesn’t need some new ideas in America. Can it use its new clinics to funnel patients to its pharmacy and not competing pharmacies?īrancaccio: Amazon is, among other things, an innovator. And you know how Amazon likes data? Can they use that data to their advantage to sell more prescriptions of their mail-order drugs than their competitors? Amazon has an online pharmacy. One, Amazon can get its hands on patient data. Gordon: There are a couple of things that you worry about with Amazon. Why would antitrust regulators be interested if it, for instance, wanted to buy a chain of clinics where people go to see a doctor or a nurse?
#Gets antitrust scrutiny on data usage tv#
It’s a streaming TV company, a cloud computing company, it’s certainly a large retailer. And hospitals are in this life-and-death battle with insurance companies about getting insurance companies to pay more.īrancaccio: Another one that’s in the news here: Amazon, right? Not a hospital chain. They’ll also have a lot more power to deal with insurance companies. What about doctors who are going out looking for jobs? If those hospitals merge, they won’t bid against each other to pay doctors higher pay. Suppose one is, well, in Maryland and the other one is in Pennsylvania. For example, suppose the hospitals aren’t across the street from each other. And there are several new kinds of consolidations that are troubling to antitrust law. And that’s one kind of consolidation, but only one kind.Įrik Gordon: Yes.
OK: If Hospital A wants to merge with Hospital Y across the street, you can imagine why antitrust regulators might want to ask some questions. He spoke with “Marketplace Morning Report” host David Brancaccio and the following is an edited transcript of their conversation.ĭavid Brancaccio: So consolidation in the health care area. And they’re likely to continue scrutinizing these kinds of health care-Big Tech deals, according to Erik Gordon, a professor at the University of Michigan’s Ross School of Business. While the FTC decided not to block this merger, antitrust officials are still investigating it. The Federal Trade Commission, on the other hand, has been keeping a close watch on this for potential antitrust violations. Amazon sees health care as an area ripe for disruption and opportunity. Last week, Amazon closed a deal to buy a chain of health care clinics run by provider One Medical.
0 kommentar(er)
